Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-053878

Director sold 6,400 shares at $21.72 ($139,008)

From the SEC's structured data for this filing

Trades in this filing

CHESS ROBERT · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-09-21 Sale : show line 1 in the form −6,400 $21.72 $139,008 274,223 D
Open-market sales · 6,400 sh · avg $21.72 · $139,008
Loading xslF345X03/doc4.xml…